CD43 (sialophorin, leukosialin) shedding is an initial event during neutrophil migration, which could be closely related to the spreading of adherent cells

被引:23
作者
Lopez, S
Seveau, S
Lesavre, P
Robinson, MK
Halbwachs-Mecarelli, L
机构
[1] Hop Necker Enfants Malad, INSERM U90, F-75015 Paris, France
[2] Celltech Ltd, Slough SL1 4EN, Berks, England
关键词
CD43; shedding; adhesion; spreading; neutrophils;
D O I
10.3109/15419069809040288
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leukosialin is a negatively-charged mucin-like membrane protein of leukocytes. This anti-adhesive molecule prevents uncontrolled cellular interactions and is proteolytically cleaved during neutrophil activation. CD43 is shed in vivo during neutrophil migration to the inflammatory site. We have analysed the decrease in CD43 expression during in vitro adherence of TNF-alpha activated PMN. CD43 was quantitated by flow cytometry on TNF-alpha-activated PMN either maintained in suspension or allowed to adhere then detached with EDTA. Although TNF did not induce significant modification of CD43 expression on suspended cells, we showed that 40% of membrane CD43 is released during neutrophil TNF-induced adhesion to serum-coated plates or endothelial cells, and that migration through the endothelial monolayer did not result in further shedding. Adhesion-blocking anti-beta 2 integrin mAbs prevented CD43 shedding. beta 2 integrin "activation" by anti-CD18 mAbs or Mn ions did not decrease CD43 expression if adhesion was prevented by stirring. Inhibitors of signal transduction or of cytoskeleton association, which allowed cells to adhere but not to spread, inhibited the shedding of CD43 during adhesion. We conclude that CD43 shedding is not promoted by beta 2 integrins engagement or adhesion but is concomitant with spreading of adherent cells.
引用
收藏
页码:151 / 160
页数:10
相关论文
共 32 条
[1]  
ALTIERI DC, 1991, J IMMUNOL, V147, P1891
[2]   KIM185, A MONOCLONAL-ANTIBODY TO CD18 WHICH INDUCES A CHANGE IN THE CONFORMATION OF CD18 AND PROMOTES BOTH LFA-1-DEPENDENT AND CR3-DEPENDENT ADHESION [J].
ANDREW, D ;
SHOCK, A ;
BALL, E ;
ORTLEPP, S ;
BELL, J ;
ROBINSON, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2217-2222
[3]   CD43, THE MAJOR SIALOGLYCOPROTEIN OF HUMAN-LEUKOCYTES, IS PROTEOLYTICALLY CLEAVED FROM THE SURFACE OF STIMULATED LYMPHOCYTES AND GRANULOCYTES [J].
BAZIL, V ;
STROMINGER, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :3792-3796
[4]  
BERTON G, 1994, J CELL BIOL, V126, P111
[5]   DOWN-REGULATION BY TUMOR-NECROSIS-FACTOR-ALPHA OF NEUTROPHIL CELL-SURFACE EXPRESSION OF THE SIALOPHORIN CD43 AND THE HYALURONATE RECEPTOR CD44 THROUGH A PROTEOLYTIC MECHANISM [J].
CAMPANERO, MR ;
PULIDO, R ;
ALONSO, JL ;
PIVEL, JP ;
PIMENTELMUINOS, FX ;
FRESNO, M ;
SANCHEZMADRID, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (12) :3045-3048
[6]   DIVALENT-CATION REGULATION OF THE FUNCTION OF THE LEUKOCYTE INTEGRIN LFA-1 [J].
DRANSFIELD, I ;
CABANAS, C ;
CRAIG, A ;
HOGG, N .
JOURNAL OF CELL BIOLOGY, 1992, 116 (01) :219-226
[7]   ADHESION-DEPENDENT PROTEIN TYROSINE PHOSPHORYLATION IN NEUTROPHILS TREATED WITH TUMOR-NECROSIS-FACTOR [J].
FUORTES, M ;
JIN, WW ;
NATHAN, C .
JOURNAL OF CELL BIOLOGY, 1993, 120 (03) :777-784
[8]   Neutrophil serine proteases are most probably involved in the release of CD43 (leukosialin, sialophorin) from the neutrophil membrane during cell activation [J].
HalbwachsMecarelli, L ;
Bessou, G ;
Lesavre, P ;
Renesto, P ;
Chignard, M .
BLOOD, 1996, 87 (03) :1200-1202
[9]   EXPRESSION OF L-SELECTIN, CD43, AND CD44 IN SYNOVIAL-FLUID NEUTROPHILS FROM PATIENTS WITH INFLAMMATORY JOINT DISEASES - EVIDENCE FOR A SOLUBLE FORM OF L-SELECTIN IN SYNOVIAL-FLUID [J].
HUMBRIA, A ;
DIAZGONZALEZ, F ;
CAMPANERO, MR ;
ARROYO, AG ;
LAFFON, A ;
GONZALEZAMARO, R ;
SANCHEZMADRID, F .
ARTHRITIS AND RHEUMATISM, 1994, 37 (03) :342-348
[10]   CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA [J].
JAFFE, EA ;
NACHMAN, RL ;
BECKER, CG ;
MINICK, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) :2745-2756